Sun’s Teriparatide And Multiple Aubagio Rivals Among CHMP Recommendations

Accord Healthcare And Viatris’ Mylan Receive Nods For Generics

Sun’s rival to Forsteo, Accord and Mylan’s versions of Aubagio and Accord’s Nexavar generic were all endorsed by the European Medicines Agency at the CHMP’s September meeting.

Europe from space
Multiple products were endorsed for the European market • Source: Shutterstock

Multiple hybrid and generic medicines were granted positive opinions by the European Medicines Agency’s Committee for Medicinal Products for Human Use at its September meeting, with these recommendations to grant European marketing authorizations coming on top of a similar nod for Stada and Xbrane’s Ximluci (ranibizumab) biosimilar rival to Lucentis (see sidebar).

Sun Pharmaceutical Industries received a positive CHMP opinion for its version of osteoporosis treatment Forsteo (teriparatide). However, unlike certain other...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin